Check out our most popular compounded medications! Get Started
The Estradiol 2.8 mg/Estriol 1.2 mg/Testosterone 2.5 mg Oral Troches are square-shaped solid dosage forms intended for buccal administration. These troches are formulated to dissolve slowly in the mouth, allowing for the absorption of the active ingredients through the oral mucosa. This method of delivery aims to provide targeted local or systemic effects.
This compounded medication combines estradiol and estriol, both forms of estrogen, with testosterone. It is commonly used in hormone replacement therapy for individuals experiencing symptoms associated with menopause, such as hot flashes, vaginal dryness, and bone loss. Additionally, this formulation may be prescribed to address conditions related to hormonal imbalances, such as certain cases of androgen deficiency. By delivering hormones directly through the oral mucosa, these troches may offer an alternative to oral or parenteral routes, potentially reducing gastrointestinal side effects and first-pass metabolism.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The formulation of Estradiol 2.8 mg/Estriol 1.2 mg/Testosterone 2.5 mg Oral Troches is a compounded medication specifically designed to address hormone replacement therapy needs in patients experiencing hormonal imbalances or deficiencies. These square-shaped solid dosage forms are intended for buccal administration, where they are placed in the mouth and allowed to dissolve slowly, facilitating the absorption of the active ingredients directly through the oral mucosa. This method of delivery is advantageous as it bypasses the gastrointestinal tract, potentially reducing the first-pass metabolism and enhancing bioavailability.
Estradiol and Estriol are forms of estrogen, a hormone that plays a critical role in the regulation of many processes in the body, including the menstrual cycle and reproductive system in women. Estradiol is the most potent form of estrogen and is often used to treat symptoms of menopause such as hot flashes, vaginal dryness, and osteoporosis. Estriol, being a weaker form of estrogen, is thought to offer some of the benefits of estrogen replacement with potentially fewer side effects. The combination of these two estrogens in the troche aims to provide a balanced approach to estrogen therapy, addressing symptoms while considering safety and tolerability.
Testosterone, included in the formulation at 2.5 mg, is a hormone that is important for both men and women, although it is typically associated with male characteristics and reproductive functions. In women, testosterone is used to improve libido, energy levels, and mood. It can also contribute to bone density and muscle strength. In men, testosterone replacement therapy is used to treat conditions associated with a deficiency or absence of endogenous testosterone (hypogonadism).
This compounded troche formulation is tailored for patients who may require a customized dosage of hormones that is not available in standard commercial products. It is particularly useful for patients who have specific needs that are not met by conventional hormone replacement therapies. The combination of estradiol, estriol, and testosterone in a single troche can simplify the regimen and potentially improve patient compliance.
It is important for both patients and prescribers to understand that this is a compounded medication and should be used under the guidance of a healthcare professional with expertise in hormone replacement therapy. The specific dosages of estradiol, estriol, and testosterone have been chosen to provide a balanced effect, but as with all medications, there may be risks associated with their use. Patients should be monitored for side effects and the effectiveness of therapy should be regularly evaluated by their healthcare provider.
For those interested in this formulation or who have further questions regarding its use, indications, or potential side effects, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is available to provide the necessary information and support to ensure appropriate treatment with this customized medication.
The estradiol, estriol, and testosterone oral troches are compounded hormone replacement therapies that are absorbed through the oral mucosa. These hormones can interact with a variety of medications, and it is important for both patients and prescribers to be aware of these potential interactions to avoid adverse effects or diminished efficacy of treatment.
Estradiol and estriol are forms of estrogen, and when used in combination with testosterone, they can interact with thyroid hormone replacement therapy. Estrogens may increase thyroid-binding globulin (TBG) levels, leading to decreased thyroid hormone activity and necessitating adjustments in thyroid replacement dosing. Patients on thyroid replacement therapy should have their thyroid function monitored closely when starting or adjusting doses of these hormones.
Concomitant use of estrogens with corticosteroids may result in increased metabolism of the corticosteroid, potentially reducing its effects. Patients taking corticosteroids should be monitored for reduced efficacy and dosage adjustments may be necessary. Additionally, estrogens can inhibit the metabolism of cyclosporine, leading to increased cyclosporine plasma levels and an increased risk of toxicity. Cyclosporine levels should be monitored and dosage adjustments made as needed.
Estrogens can also potentiate the effects of anticoagulant drugs, such as warfarin, which may increase the risk of bleeding. Patients on anticoagulant therapy should have their coagulation parameters closely monitored, especially when starting or changing the dose of hormone therapy. Similarly, estrogens may affect the metabolism of certain benzodiazepines, tricyclic antidepressants, and other medications metabolized by cytochrome P450 enzymes, potentially leading to increased plasma concentrations and enhanced or prolonged effects.
Testosterone can interact with oral anticoagulants, increasing the risk of bleeding. Patients on oral anticoagulants should be closely monitored, particularly when initiating or discontinuing testosterone therapy. Testosterone may also affect blood glucose levels, and patients with diabetes should be monitored for changes in blood glucose and insulin or oral hypoglycemic dosage adjustments may be necessary.
It is also important to note that smoking can increase the risk of serious cardiovascular side effects from estrogen use. Patients who smoke should be advised of this risk and encouraged to quit. Additionally, certain herbal products and over-the-counter medications may interact with hormone therapy, so patients should inform their healthcare provider of all medications and supplements they are taking.
This compounded formulation is used to treat various conditions such as menopausal symptoms, hormone deficiencies, and certain cases of hormonal imbalance. The specific ratio of estradiol, estriol, and testosterone is tailored to address individual patient needs and should be used under the guidance of a healthcare provider experienced in hormone replacement therapy.
Patients and prescribers should be aware that this is not an exhaustive list of all potential drug interactions. It is essential to review all current medications, including over-the-counter drugs and dietary supplements, with a healthcare provider to ensure safety and efficacy of the hormone therapy. If you have any questions or concerns regarding this formulation or its interactions with other medications, please reach out to us at Bayview Pharmacy for further assistance.
The formulation of Estradiol 2.8 mg/Estriol 1.2 mg/Testosterone 2.5 mg Oral Troches is a compounded medication that combines three hormones to address various conditions related to hormonal imbalances or deficiencies. These square-shaped solid dosage forms are specifically designed to dissolve slowly in the mouth, which allows for the medication to be absorbed directly through the oral mucosa. This method of delivery is beneficial as it bypasses the gastrointestinal tract and the first-pass metabolism in the liver, potentially reducing the risk of systemic side effects and improving the bioavailability of the hormones.
Estradiol and estriol are forms of estrogen, a hormone that plays a critical role in the regulation of the female reproductive system and secondary sexual characteristics. Estradiol is the most potent form of estrogen and is often used to treat symptoms of menopause such as hot flashes, vaginal dryness, and osteoporosis. Estriol, being a weaker estrogen, is thought to offer some of the benefits of estrogen replacement with potentially fewer risks. The combination of estradiol and estriol in this troche aims to provide a balanced estrogen replacement therapy that can alleviate menopausal symptoms while minimizing side effects.
Testosterone, although commonly recognized as a male hormone, is also important in females for bone strength, brain function, and the maintenance of libido. The inclusion of testosterone in this formulation can help address conditions such as hypoactive sexual desire disorder (HSDD) in women, especially during the postmenopausal period when the body's natural production of testosterone declines.
By delivering these hormones through the oral mucosa, the troches can be used to treat not only local symptoms like vaginal atrophy but also systemic conditions such as menopausal symptoms, certain cases of osteoporosis, and HSDD. The precise dosing and combination of hormones in this formulation are tailored to meet the specific needs of the patient, which should be determined by a healthcare provider based on individual symptoms, hormone levels, and risk factors.
It is important for both patients and prescribers to understand that hormone replacement therapy with these troches should be approached with care, considering the potential risks and benefits. Monitoring and regular follow-up with a healthcare provider are essential to ensure the safety and efficacy of the treatment. If you have any questions or require further information about this formulation and its use in treating hormonal imbalances or deficiencies, please reach out to us at Bayview Pharmacy.
Estradiol 2.8 mg/Estriol 1.2 mg/Testosterone 2.5 mg Oral Troches are compounded hormone replacement therapy medications designed for patients who require a specific combination of estrogen and testosterone. They can be used to address symptoms related to hormonal imbalances or deficiencies, such as menopausal symptoms, andropause, or other conditions as determined by a healthcare provider.
To use these oral troches, place one troche in your mouth and allow it to dissolve slowly. Do not chew or swallow the troche. The medication is absorbed through the oral mucosa. Follow your healthcare provider's dosing instructions carefully.
The frequency of dosing for these oral troches will depend on your specific treatment plan provided by your healthcare provider. It's important to use this medication exactly as prescribed.
It is recommended to wait at least 15-30 minutes after the troche has completely dissolved before eating or drinking. This allows the medication to be fully absorbed through the oral mucosa.
If you miss a dose, take it as soon as you remember. However, if it's almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one.
As with any medication, there can be side effects. Common side effects may include irritation in the mouth where the troche was placed, nausea, headache, or changes in mood. If you experience any severe side effects or signs of an allergic reaction, contact your healthcare provider immediately.
These oral troches are generally not recommended for use during pregnancy or breastfeeding. Consult your healthcare provider for advice before starting any new medication if you are pregnant, planning to become pregnant, or are breastfeeding.
Store the oral troches at room temperature, away from light, moisture, and excessive heat. Keep them in their original packaging until it's time to take them, and keep them out of reach of children and pets.
Yes, other medications, supplements, or herbal products may interact with the hormones in these troches, potentially affecting their efficacy or increasing the risk of side effects. Make sure to discuss all your current medications with your healthcare provider.
The duration of treatment with these oral troches can vary widely among individuals. Your healthcare provider will determine the appropriate treatment duration based on your health status, symptoms, and therapeutic goals.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place 1 troche between cheek and gum and let slowly dissolve
